Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:2773
doi: 10.1161/CIRCULATIONAHA.107.187682
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2007;116:2773.)
© 2007 American Heart Association, Inc.

Issue Highlights


*    CAN COMMON-TYPE ATRIAL FLUTTER BE A SIGN OF AN ARRHYTHMOGENIC SUBSTRATE IN PAROXYSMAL ATRIAL FIBRILLATION? CLINICAL AND ABLATIVE CONSEQUENCES IN PATIENTS WITH COEXISTENT PAROXYSMAL ATRIAL FIBRILLATION/ATRIAL FLUTTER, by Moreira et al
up arrowTop
*CAN COMMON-TYPE ATRIAL FLUTTER...
down arrowDOES COMORBIDITY ACCOUNT FOR...
down arrowNF-{kappa}B IS A KEY...
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
Common atrial flutter due to right atrial reentry is often associated with atrial fibrillation, although the critical substrate for atrial fibrillation is more often left atrial. Moreira and coworkers performed sequential ambulatory monitoring and ablation studies in patients with paroxysmal atrial fibrillation to define the presence of atrial flutter and assess the impact of right atrial flutter ablation and segmental pulmonary vein isolation with cryoablation on spontaneous arrhythmias. As expected, right atrial ablation alone was effective for abolishing atrial flutter but failed to prevent atrial fibrillation. Interestingly, pulmonary vein isolation was substantially less effective in preventing recurrent atrial fibrillation in patients with prior atrial flutter than in those with no prior atrial flutter. These findings suggest that atrial flutter is a marker for more advanced atrial disease in patients with paroxysmal atrial fibrillation. Monitoring for atrial flutter may provide a noninvasive means of assessing the extent of arrhythmia substrate that might help predict outcomes and potentially facilitated more individualized ablation strategies. See p 2786 (editorial p 2774).


*    DOES COMORBIDITY ACCOUNT FOR THE EXCESS MORTALITY IN PATIENTS WITH MAJOR BLEEDING IN ACUTE MYOCARDIAL INFARCTION? by Spencer et al
up arrowTop
up arrowCAN COMMON-TYPE ATRIAL FLUTTER...
*DOES COMORBIDITY ACCOUNT FOR...
down arrowNF-{kappa}B IS A KEY...
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
Major bleeding after treatment for acute myocardial infarction is associated with a significantly worse overall outcome in randomized clinical trials. However the incidence in an unselected group of patients and the factors associated with an increased bleeding risk are not well described. 40 089 patients with acute myocardial infarction were enrolled in the Global Registry of Acute Coronary Events (GRACE) registry. The frequency of major bleeding in patients with acute myocardial infarction was 2.8%. In-hospital mortality was increased significantly (hazard ratio=1.9, 95% confidence interval 1.6–2.2) and accounted for 10% of all hospital deaths. Major bleeding was not a predictor of mortality after hospital discharge. Bleeding was associated with invasive procedures, age, and comorbidities, as well as premature discontinuation of antithrombotic therapy. This study suggests that bleeding is related to adverse outcomes and is often a marker for patients at higher risk for adverse outcomes. See p 2793 (editorial p 2776).


*    NF-{kappa}B IS A KEY MEDIATOR OF CEREBRAL ANEURYSM FORMATION, by Aoki et al
up arrowTop
up arrowCAN COMMON-TYPE ATRIAL FLUTTER...
up arrowDOES COMORBIDITY ACCOUNT FOR...
*NF-{kappa}B IS A KEY...
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
Cerebral aneurysms are an important source of morbidity and mortality, yet we know very little about the mechanisms of aneurysm formation. In this issue, Aoki and colleagues demonstrate that a key mediator of inflammation, known as NF-{kappa}B, is required for the development of cerebral aneurysms. Inhibition of this target prevented the formation of aneurysms in animal models. Most importantly, examination of human specimens revealed this NF-{kappa}B pathway to be activated in cerebral aneurysms. This study provides us with a potential new therapeutic target for patients in whom early aneurysm formation is noted. See p 2830.

Visit http://circ.ahajournals.org:


*    Images in Cardiovascular Medicine
up arrowTop
up arrowCAN COMMON-TYPE ATRIAL FLUTTER...
up arrowDOES COMORBIDITY ACCOUNT FOR...
up arrowNF-{kappa}B IS A KEY...
*Images in Cardiovascular...
down arrowCorrespondence
 
Leiomyosarcoma Involving Main and Left Pulmonary Artery Treated Surgically With Homograft Replacement and Concomitant Left Pneumonectomy. See p e559.


Figure 15631
View larger version (111K):
[in this window]
[in a new window]

 


*    Correspondence
up arrowTop
up arrowCAN COMMON-TYPE ATRIAL FLUTTER...
up arrowDOES COMORBIDITY ACCOUNT FOR...
up arrowNF-{kappa}B IS A KEY...
up arrowImages in Cardiovascular...
*Correspondence
 
See p e562.


Related Articles:

Atrial Fibrillation–Atrial Flutter Interactions: Clinical Implications for Ablation
Albert L. Waldo
Circulation 2007 116: 2774-2775. [Full Text]

Bleeding Is Bad.... Isn’t It?
Peter B. Berger and Steven V. Manoukian
Circulation 2007 116: 2776-2778. [Full Text]

Leiomyosarcoma Involving Main and Left Pulmonary Artery Treated Surgically With Homograft Replacement and Concomitant Left Pneumonectomy
Sak Lee, In-Kyu Park, Sang-Ho Cho, and Do-Kyun Kim
Circulation 2007 116: e559-e561. [Full Text]

Letter by Tartière et al Regarding Article, "Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota"
Jean-Michel Tartière, Lamia Tartière-Kesri, and Alain Cohen Solal
Circulation 2007 116: e562. [Full Text]

NF-{kappa}B Is a Key Mediator of Cerebral Aneurysm Formation
Tomohiro Aoki, Hiroharu Kataoka, Munehisa Shimamura, Hironori Nakagami, Kouji Wakayama, Takuya Moriwaki, Ryota Ishibashi, Kazuhiko Nozaki, Ryuichi Morishita, and Nobuo Hashimoto
Circulation 2007 116: 2830-2840. [Abstract] [Full Text]




This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles